Are you or a loved one interested in receiving stem cell treatment? For free information, please fill out our
treatment form or email me don@repairstemcells.org and just put TREATMENT in the subject box and the MEDICAL CONDITION in the message.
THIS NATIONAL REVIEW ONLINE ARTICLE HITS THE NAIL ON THE HEAD. THE AUTHOR GIVES MORE EVIDENCE OF THE BIAS AGAINST ADULT STEM CELL RESEARCH THAT IS ROBBING AMERICANS OF THEIR TAX DOLLARS. MEMO TO CALIFORNIANS- READ THIS ARTICLE AND SEE WHERE YOUR TAX DOLLARS ARE BEING SPENT:
UPDATE: Sometimes I get so angry about the bias shown towards adult stem cell therapy that I forget why I started this blog in the first place. I thank the adult stem cell awareness blog for reminding me - this injustice against adult stem cell research and Dr. Lubin has a bright side in that it brought more attention to Dr. Lubin's success with sickle cell anemia: if you or someone you know has sickle cell anemia, you should try to reach Dr. Lubin for a safe and probably effective therapy. I suggest going to the website of the Children's Hospital Oakland Research Institute for more information.When Dr. Bertram Lubin, head of the Children's Hospital Oakland Research Institute, applied for a $5 million facilities grant last fall from the California Institute for Regenerative Medicine (CIRM) to support his research on sickle-cell anemia, his colleagues thought the application was a slam dunk.The CIRM the agency that distributes grants and loans under California's voter-approved $3 billion stem-cell initiative thought otherwise. So, why was Lubin's application shot down?
Lubin's clinical data, in the opinion of his colleagues and independent observers, was solid. His request in response to an RFA for facilities grants was modest in comparison to the eight-figure grants the CIRM eventually approved. He just wanted to build new labs for the Children's Hospital. And Lubin is no second-string researcher: His work is supported by the NIH, and he has served on many NIH peer-review committees. Lubin's research, which focuses on adult stem cells derived from the placenta, could arguably translate almost immediately into therapeutic applications to the benefit of millions of black children who suffer atrociously from the effects of sickle cell anemia. About 1,000 babies a year are born with the genetic disease in the United States.As it turns out, Lubin's work was faulted among other things, according to a summary on the CIRM website, for showing “no evidence of current use or planned expansion into the use of human embryonic stem cells.This is a must read! Click Here to Read The Whole Thing